NCT04548427View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of CKD-352

PHASE3CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

September 22, 2020

Primary Completion Date

May 7, 2021

Study Completion Date

May 7, 2021

Conditions
Dry Eye Disease
Interventions
DRUG

CKD-352

Eye Drop

DRUG

Diquafosol Sodium 3%

Eye Drop

Trial Locations (1)

Unknown

Pusan National University Hospital, Pusan

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY